PPARα Activation Overcomes Fibroinflammatory Anti-PD-1 Resistance in Liver Cancer via GSDME Pyroptosis
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
In a groundbreaking study poised to redefine therapeutic strategies for non-small cell lung cancer (NSCLC), researchers have unveiled the potent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine